Concerta ER 18 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH7Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,776
Award facts
- Contract value 100% obligated
- $9,775.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Concerta ER 18 mg tablets (100-count units) valued at $9,775.73. The contract utilizes a firm fixed-price structure with an ultimate completion date of January 15, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle extending through December 2031 that serves as the primary procurement mechanism for pharmaceutical and medical supply distribution across military healthcare systems globally. The award was made on a full and open competitive basis with no set-aside designation.
This contract reflects AmerisourceBergen's continued role as a critical pharmaceutical distributor for federal military healthcare operations. The company, headquartered in Conshohocken, Pennsylvania, maintains extensive experience fulfilling government medical procurement requirements across diverse therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. The delivery order for Concerta ER—a controlled-release methylphenidate treatment typically used for attention deficit conditions—represents routine task order activity under the larger IDC vehicle that enables DLA to efficiently procure essential pharmaceutical commodities supporting military treatment facilities, veteran healthcare programs, and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FJH7Q?
SPE2DR26FJH7Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH7Q worth?
The government has obligated $9,776 on SPE2DR26FJH7Q.
Is contract SPE2DR26FJH7Q an order under another contract?
Yes. SPE2DR26FJH7Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH7Q competed?
The extent of competition for SPE2DR26FJH7Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award